Drug Maker Confirms $2.4B Bayer Bid
Tue., Nov. 26, 2013
By Greg Hazley
Norwegian cancer drug maker Algeta today confirmed media reports that partner Bayer has pitched a $2.4B acquisition deal.
Read Full Story in Subscriber Area
Category: Financial PR & Investor Relations
More Financial PR & Investor Relations posts from O'Dwyer's:
• | Teneo Handles CVC Capital’s IPOMon., Apr. 15, 2024 |
• | Brunswick, Edelman Smithfield Work Endeavor’s $13B DealWed., Apr. 3, 2024 |
• | Donhauser Takes Helm of H/Advisors Abernathy's SF UnitMon., Mar. 25, 2024 |
• | Intelligent Group IR Firm Lists on NASDAQWed., Mar. 20, 2024 |
• | Kekst CNC, Goldin Work Grant Thornton DealFri., Mar. 15, 2024 |
No comments have been submitted for this story yet.